Document:

f8k050609ex10iii_mit.htm

    Exhibit 10.3

     

    
      THE
SECURITIES THAT ARE THE SUBJECT OF THIS STOCK PURCHASE AGREEMENT HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR UNDER THE APPLICABLE
SECURITIES LAWS OF ANY STATE AND WILL BE OFFERED AND SOLD IN RELIANCE ON
EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF THESE LAWS BY VIRTUE OF THE
INTENDED COMPLIANCE BY THE ISSUER WITH REGULATION S OF THE SECURITIES
ACT.  THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE
U.S. SECURITIES AND EXCHANGE COMMISSION (THE “SEC”), ANY STATE SECURITIES
COMMISSION OR ANY OTHER REGULATORY AUTHORITY.  ANY REPRESENTATION TO
THE CONTRARY IS A CRIMINAL OFFENSE.

      
 

      

      STOCK
PURCHASE AGREEMENT

      

      THIS SUBSCRIPTION AGREEMENT
(the “Agreement”) is made and entered into as of this 22th day of
May, 2009, by and between Medical International Technology,
Inc. a Colorado corporation (the “Company”), with its offices located at
1872 Beaulac Montreal (Saint-Laurent) QC Canada H4R 2E7 and  with its
address located at    (the
“Purchaser”).

      

      RECITALS:

      

      WHEREAS, the Company is
offering for sale­­______________ (_____) units (individually, a
“Unit” and, collectively, the “Units”), each Unit consisting of one share of
(POST REVERSE SPLIT) common stock, $0.0001 par value per share (the “Common
Stock”) at a per Unit price of $0.14, in a transaction exempt
from registration under Regulation S of the Securities Act of 1933, as amended
(the “Securities Act”), and the regulations promulgated thereunder.

      

      NOW, THEREFORE, in
consideration of the premises and other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the parties hereto
agree as follows:

      

      SECTION
1.0: PURCHASE AND SALE OF UNITS.

      

      Section 1.1  Closing.  The Company
agrees to issue, sell and deliver to the Purchaser, and the Purchaser agrees to
purchase and receive from the Company, _______(_______) Units upon the terms
and conditions set forth in this Agreement.  The closing (the
“Closing”) of the sale and purchase of the Units shall take place at the
Company’s offices, at 12:00, local time, on May 22th , 2009, or at such other time
and place as may be agreed to by the parties (the “Closing
Date”).  The Units, shall be restricted and the certificates
representing the securities shall bear the restrictive legend pursuant to Rule
144 of the General Rules and Regulations under the Securities Act.

      

      Section 1.2  Purchase
Price.  The total
purchase price for the Units (the “Purchase Price”) shall consist of cash in the
amount of ________(_____) US
DOLLARS.

      

      SECTION
2.0: REPRESENTATIONS AND WARRANTIES.

       

       

      
        
          
          

        

        
          - 1 -

          
            

          

        

        
          
          

        

      

      
 

      Section 2.1  Representations
and Warranties of the Purchaser. The Purchaser makes the following
representations and warranties to the Company.

      

      (a)  Speculative
Investment.  The Purchaser is aware that an investment in the
Units is highly speculative and subject to substantial risks.  The
Purchaser is capable of bearing the high degree of economic risk and the burden
of this venture, including, but not limited to, the possibility of complete loss
of the Purchaser’s investment in the Units that makes liquidation of this
investment impossible for the indefinite future.

      

      (b)  Privately
Offered.  The offer to issue and sell the Units was
communicated directly to the Purchaser in such a manner that the Purchaser was
able to ask questions of and receive answers concerning the terms and conditions
of this transaction.  At no time was the Purchaser presented with or
solicited by or through any leaflet, public promotional meeting, television
advertisement or any other form of general advertising.

      

      (c)  Purchase for
Investment.  The Units are being acquired solely for the
Purchaser’s own account, for investment purposes and are not being purchased
with a view to the resale, distribution, subdivision or fractionalization
thereof without proper registration with appropriate securities administrators
or an applicable exemption from such registration.  The Purchaser will
comply with all applicable law with respect to any resale of the
Units.

      

      (d)  Access to
Information.  The Purchaser or the Purchaser’s professional
advisor has been granted the opportunity to ask questions of and receive answers
from representatives of the Company and its officers, directors, employees and
agents concerning the terms and conditions of the offering of the Units, the
Company and its business and prospects, and to obtain any additional information
that the Purchaser or the Purchaser’s professional advisor deems necessary to
verify the accuracy and completeness of the information received.

      

      (f)  Reliance on Own
Advisors.  The Purchaser has relied on the advice of, or has
consulted with, the Purchaser’s own tax, investment, legal or other advisors and
has not relied on the Company or any of it affiliates, officers, directors,
attorneys, accountants or any affiliates of any thereof and each other person,
if any, who controls any thereof, within the meaning of Section 15 of the
Securities Act, for any tax or legal advice.  The foregoing, however,
does not limit or modify the Purchaser’s right to rely upon representations and
warranties of the Company in Section 2.2 of this Agreement and any
representations of any third parties acting as agents for or on the Company’s
behalf.

      

      (g)  Capability to
Evaluate.  The Purchaser has such knowledge and experience in
financial and business matters so as to enable such Purchaser to utilize the
information made available to it in connection with the offer of the Securities
in order to evaluate the merits and risks of the prospective
investment.

      

      (h)  Authority.  The
Purchaser (and each of its subsidiaries, if applicable) is a corporation duly
incorporated and existing in good standing under the laws of the State of New
York and has the requisite corporate power to own its properties and to carry on
its business as now being conducted.  The Purchaser has full power and
authority to execute and deliver this Agreement and each other document included
herein (if any) for which a signature is required and to act in accordance with
the terms of this Agreement and such other documents (if any).

       

      
        
          
          

        

        
          - 2 -

          
            

          

        

        
          
          

        

      

       

      
 

      (i) Non United States
Person.  The Undersigned is not a US person under Rule 902 of
Regulation S under the Securities Act, and is not acquiring the Stock for the
account or benefit of any US person; and is, if a natural person, over 21 years
of age.

      

      The
foregoing representations and warranties shall be true and accurate as of the
date hereof and as of the date of any acceptance of this Offer by the Company
and shall survive the date of such acceptance by the Company.

      

      Section 2.2  Representations
and Warranties of the Company.  The Company
hereby makes the following representations and warranties to the
Purchaser:

      

      (a)  Organization and
Qualification.  The Company is a corporation duly incorporated
and existing in good standing under the laws of the state of Colorado and has
the requisite corporate power to own its properties and to carry on its business
as now being conducted.

      

      (b)  Authorization;
Enforcement.  (i) The Company has the requisite corporate power
and authority to enter into and perform this Agreement and to issue and sell the
Units in accordance with the terms hereof; (ii) the execution and delivery of
this Agreement by the Company and the consummation by it of the transactions
contemplated hereby have been duly authorized by all necessary corporate action,
and no further consent or authorization of the Company or its Board of Directors
or stockholders is required; (iii) this Agreement has been duly executed and
delivered by the Company; and (iv) this Agreement constitutes a valid and
binding obligation of the Company enforceable against the Company in accordance
with its terms (except as such enforceability may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws
relating to, or affecting generally, the enforcement of, creditors’ rights and
remedies or by other equitable principles of general application).

      

      (c)  Authorized Capital; Rights
or Commitments to Stock.  As of April 1st 2009,
the authorized capital stock of the Company consists of 103,000,000 shares, of
which 100,000,000 shares are Common Stock, of which 53,058,663 shares are issued
and outstanding, and 3,000,000 shares are preferred stock, of which no shares
are issued and outstanding.  All of the outstanding shares of the
Company’s Common Stock have been validly issued and are fully paid and
non-assessable.

      

      (d)  Issuance of
Securities.  The issuance of the Units has been duly authorized
and, when paid for and issued in accordance with the terms hereof, the Units,
shall be validly issued, fully paid and non-assessable
and entitled to the rights inherent in the securities and as specified
herein.

      

      (e)  No
Conflicts.  The execution, delivery and performance of this
Agreement by the Company and the consummation by the Company of the transactions
contemplated hereby do not and will not (i) result in a violation of the
Company’s Articles of Incorporation or Bylaws or (ii) conflict with, or
constitute a default (or an event that with notice or lapse of time or both
would become a default) under, or give to others any rights of termination,
amendment, acceleration or cancellation of, any agreement, indenture or
instrument to which the Company or any of its subsidiaries is a party, or result
in a violation of any federal, state, local or foreign law, rule, regulation,
order, judgment or decree (including federal and state securities laws and
regulations) applicable to the Company its subsidiary or by which any property
or assets of the Company or its subsidiary is bound or affected (except for such
conflicts, defaults, terminations, amendments, accelerations, cancellations and
violations as would not, individually or in the aggregate, have a Material
Adverse Effect); provided that, for purposes of such representation as to
federal, state, local or foreign law, rule or regulation, no representation is
made herein with respect to any of the same applicable solely to the Purchaser
and not to the Company.  The business of the Company is not being
conducted in violation of any law, ordinance or regulations of any governmental
entity, except for violations that either singly or in the aggregate do not and
will not have a Material Adverse Effect.  The Company is not required
under federal, state or local law, rule or regulation in the United States to
obtain any consent, authorization or order of, or make any filing or
registration with, any court or governmental agency in order for it to execute,
deliver or perform any of its obligations under this Agreement or issue and sell
the Units in accordance with the terms hereof, and the payment of any filing or
other fees required by such governing authority; provided that, for purposes of
the representation made in this sentence, the Company is assuming and relying
upon the accuracy of the relevant representations and agreements of the
Purchaser herein.

       

      
        
          
          

        

        
          - 3 -

          
            

          

        

        
          
          

        

      

      
 

      (f)  Reporting Status. The
Company is subject to the reporting requirements of Section 13 of the Securities
Exchange Act of 1934, as amended.  The Company is not an investment
company or a developmental stage company that has no specific business plan or
purpose.  No information or documentation provided to the Purchaser as
of the date hereof has contained any untrue statement of a material fact or has
omitted to state a material fact required to be stated therein or necessary in
order to make the statements therein, in light of the circumstances under which
they were made, not misleading.

      

      (g)  No General
Solicitation.  Neither the Company, nor any of its affiliates,
or, to the best of its knowledge, any person acting on its or their behalf, has
engaged in any form of general solicitation or general advertising in connection
with the offer or sale of the Units.

      

      (h)  No Integrated
Offering.  Neither the Company, nor any of its affiliates, nor
any person acting on its or their behalf has, directly or indirectly, made any
offers or sales of any of the Company’s securities or solicited any offers to
buy any of such securities, under circumstances that would prevent the Company
from offering the Units pursuant to Regulation S under the Securities
Act.

      

      

      SECTION
3.0: COMPLIANCE AND INSTRUCTIONS.

      

      Section 3.1  Securities
Compliance.  The Company
shall, to the extent required, notify the SEC and the NASD Over-the-Counter Pink
sheet, in accordance with their requirements, of the transactions contemplated
by this Agreement, and shall take all other necessary action and proceedings, as
may be required by applicable law, rule and regulation, for the legal and valid
issuance of the Units to the Purchaser.

      

      Section 3.2  Transfer
Agent Instructions.

      

      a.  Common Stock to be Issued With
Restrictive Legend.  Upon the Closing, the Company shall
instruct its transfer agent to issue certificates for _________(_____) shares of Common Stock
to be received by the Purchaser pursuant to this Agreement, with a restrictive
legend pursuant to Rule 144 under the Securities Act, in the name of the
Purchaser and in such denominations to be specified by the
Purchaser.

      

      SECTION 4.0: GENERAL
CONDITIONS.

      

      Section 4.1  General
Conditions Precedent to the Obligation of the Company to Sell the
Shares.  The obligation
hereunder of the Company to issue and/or sell the Units to the Purchaser is
subject to the satisfaction, at the Closing, of each of the conditions set forth
below.  These conditions may be waived by the Company at any time in
its sole discretion.

       

       

      
        
          
          

        

        
          - 4 -

          
            

          

        

        
          
          

        

      

       

      
 

      (a)  Accuracy of the Purchaser’s
Representations and Warranties.  The representations and
warranties of the Purchaser shall be true and correct in all material respects
as of the date when made and as of the Closing Date as though made at that time
(except for any representations and warranties that are effective as of a
particular, specified date).

      

      (b)  Performance by the
Purchaser.  The Purchaser shall have performed all agreements
and satisfied all conditions required to be performed or satisfied by the
Purchaser at or prior to the Closing.

      

      (c)  No Injunction, No Legal
Action.  No statute, rule, regulation, executive order, decree,
ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or governmental authority of competent jurisdiction that prohibits
the consummation of any of the transactions contemplated by this
Agreement.  No legal action, suit or proceeding shall be pending or
threatened that seeks to restrain or prohibit the transactions contemplated by
this Agreement.

      

      (d)  Purchase
Price.  The Purchaser shall have delivered the applicable
Purchase Price for the Units to be purchased, in accordance with Section 1.2
above.

      

      Section 4.2 General
Conditions Precedent to the Obligation of the Purchaser to Purchase the
Shares.  The obligation
hereunder of the Purchaser to purchase and pay for the Units is subject to the
satisfaction, at the Closing, of each of the conditions set forth
below.  These conditions may be waived by the Purchaser at any time in
its sole discretion.

      

      (a)  Accuracy of the Company’s
Representations and Warranties.  The representations and
warranties of the Company shall be true and correct in all material respects as
of the date when made and as of the Closing Date as though made at that time
(except for representations and warranties that are effective as of a
particular, specified date).

      

      (b)  Performance by the
Company.  The Company shall have performed all agreements and
satisfied all conditions required to be performed or satisfied by the Company
pursuant to this Agreement at or prior to the Closing, unless any such agreement
or condition is waived by the Purchaser in writing at or prior to
Closing.

      

      (c)  Trading and
Listing.  The Company shall not have received notice of, and
trading in the Company’s Common Stock shall not have been, suspended by the SEC
or a national securities exchange (currently the Over-the-Counter Pink sheet)
(except for any suspension of trading of limited duration agreed to between the
Company and the principal exchange on which the Common Stock is traded solely to
permit dissemination of material information regarding the Company) or de-listed
by such exchange, and trading in securities generally as reported by such
exchange shall not have at any prior time been suspended or limited, or minimum
prices shall not have been established on securities whose trades are reported
by such exchange.

      

      (d)  No
Injunction.  No statute, rule, regulation, executive order,
decree, ruling or injunction shall have been enacted, entered, promulgated or
endorsed by any court or governmental authority of competent jurisdiction that
prohibits the consummation of any of the transactions contemplated by this
Agreement.

       

       

      
        
          
          

        

        
          - 5 -

          
            

          

        

        
          
          

        

      

       

      
 

      SECTION
5.0: TERMINATION.

      

      Section 5.1  Termination.  This Agreement
may be terminated at any time prior to the Closing by the mutual written consent
of the Company and the Purchaser.  This Agreement may be terminated by
action of the respective Board of Directors or other governing body of the
Purchaser or the Company at any time if the Closing shall not have been
consummated by the fifth (5th) business day following the date of this
Agreement, provided that the party seeking to terminate the Agreement is not in
breach of the Agreement.  This Agreement shall automatically terminate
without any further action of either party hereto if the Closing shall not have
occurred by the seventh (7th) business day following the date of this Agreement,
provided, however, that any such
termination shall not terminate the liability of any party that is then in
breach of the Agreement.

      

      SECTION
6.0: MISCELLANEOUS.

      

      Section 6.1  Fees and
Expenses.  The parties shall
each pay the fees, commissions and expenses of its respective advisers, brokers,
finders, counsel, accountants and other experts, if any, and all other expenses
associated therewith, in accordance with their respective
agreements.

      

      Section
6.2  Specific Enforcement,
Consent to Jurisdiction.

      

      (a)  The
Company and the Purchaser acknowledge and agree that irreparable damage would
occur in the event that any of the provisions of this Agreement were not
performed in accordance with their specific terms or were otherwise
breached.  It is accordingly agreed that the parties shall be entitled
to an injunction or injunctions to prevent or cure breaches of the provisions of
this Agreement and to enforce specifically the terms and provisions hereof, this
being in addition to any other remedy to which either of them may be entitled by
law or equity.

      

      (b)  The
Company and the Purchaser each (i) hereby irrevocably submits to the
jurisdiction of the United States District Court and other courts of the United
States sitting in the State of Colorado for the purposes of any suit, action or
proceeding arising out of or relating to this Agreement and (ii) hereby waives,
and agrees not to assert in any such suit, action or proceeding, any claim that
it is not personally subject to the jurisdiction of such court, that the suit,
action or proceeding is brought in an inconvenient forum or that the venue of
the suit, action or proceeding is improper.  The Company and the
Purchaser each consents to process being served in any such suit, action or
proceeding by mailing a copy thereof to such party at the address in effect for
notices to it under this Agreement and agrees that such service shall constitute
good and sufficient service of process and notice thereof.  Nothing in
this paragraph shall affect or limit any right to serve process in any other
manner permitted by law.

      

      Section 6.3  Entire
Agreement: Amendment. This Agreement contains the
entire understanding of the parties with respect to the matters covered hereby
and, except as specifically set forth herein, neither the Company nor the
Purchaser makes any representation, warranty, covenant or undertaking with
respect to such matters.  No provision of this Agreement may be waived
or amended other than by a written instrument signed by the party against whom
enforcement of any such amendment or waiver is sought.

       

       

      
        
          
          

        

        
          - 6 -

          
            

          

        

        
          
          

        

      

       

      
 

      Section 6.4  Notices.  Any notice or
other communication required or permitted to be given hereunder shall be in
writing and shall be effective (a) upon hand delivery or delivery by telex (with
correct answer back received), telecopy or facsimile at the address or number
designated below (if delivered on a business day during normal business hours
where such notice is to be received) or the first business day following such
delivery (if delivered other than on a business day during normal business hours
where such notice is to be received) or (b) on the second (2nd) business day
following the date of mailing by express courier service, fully prepaid, addressed to
such address, or upon actual receipt of such mailing, whichever shall first
occur.

       

      The addresses for such communications
shall be:

      

      To the
Company:     Medical International
Technology, Inc.

          1872
Beaulac

          Montreal
(Saint-Laurent) QC

          Canada H4R
2E7

      

          Attention:  Mr.
Karim Menassa, Chairman President & Director

      

      
        	
                To
      the Purchaser:

              	
                At
      the address set forth in the first paragraph of this Agreement or as
      specified hereafter in writing by the
Purchaser.

              

      

      

      Either
party hereto may from time to time change its address for notices by giving at
least ten (10) days’ written notice of such changed address to the other party
hereto.

      

      

      Section 6.5  Waivers.  No waiver by
either party of any default with respect to any provision, condition or
requirement of this Agreement shall be deemed to be a continuing waiver in the
future or a waiver of any other provision, condition or requirement hereof, nor
shall any delay or omission of either party to exercise any right hereunder in
any manner impair the exercise of any such right accruing to it
thereafter.

      

      Section 6.6  Headings.  The headings
herein are for convenience only, do not constitute a part of this Agreement and
shall not be deemed to limit or affect any of the provisions
hereof.

      

      Section 6.7  Governing
Law.  This Agreement is
deemed made, and the transactions contemplated herein are deemed to have taken
place in, the State of Colorado.  This Agreement shall be governed by
and construed and enforced in accordance with the internal laws of the State of
Colorado without regard to such state’s principles of conflict of
laws.

      

      Section 6.8  Survival.  The
representations and warranties of the Company and the Purchaser contained in
herein and the agreements and covenants set forth in Sections 1.1 and 1.2, 2.1
and 2.2 and 4.1 and 4.2 shall survive for a period of three (3) years after the
Closing Date.

      

      Section 6.9  Publicity.  The Company
agrees that it will not disclose, and will not include in any public
announcement, the name of the Purchaser without its consent, unless and until
such disclosure is required by law or applicable regulation, and then only to
the extent of such requirement.

      

      Section 6.10  NASD. The term “NASD” or “NASD
Over-the-Counter Pink sheet” herein refers to the principal market on which the
Common Stock of the Company is traded.  If the Common Stock is listed
on a securities exchange, or if another market becomes the principal market on
which the Common Stock is traded or through which price quotations for the
Common Stock are reported, the term “NASD” or “NASD Over-the-Counter Pink sheet”
shall be deemed to refer to such exchange or other principal
market.

       

       

      
        
          
          

        

        
          - 7 -

          
            

          

        

        
          
          

        

      

       

      
 

      Section 6.11  Acceptance.  Execution and
delivery of this Agreement by the Purchaser shall constitute an offer to
purchase the Units, which offer, unless previously revoked by the Purchaser, may
be accepted or rejected by the Company, in its sole discretion for any cause or
for no cause and without liability to the Purchaser.  The Company
shall indicate acceptance of this Agreement by signing as indicated on the
signature page hereof.

      

      Section 6.12  Binding
Agreement. Upon
acceptance of this Agreement by the Company, the Purchaser agrees that it may
not cancel, terminate or revoke any agreement of the Purchaser made hereunder,
and that this Agreement shall be binding upon the successors and assigns of the
Purchaser.

      

      Section 6.13  Counterparts.  This Agreement
may be signed in multiple counterparts, which counterparts shall constitute one
and the same original instrument.

      

      Section
6.14  Severability.  If any portion of this Agreement
shall be held illegal, unenforceable, void or voidable by any court, each of the
remaining terms hereof shall nevertheless remain in full force and effect as a
separate contract.

      

      

      Section 6.15  Successors
and Assigns.  This Agreement
shall be binding upon and inure to the benefit of the parties hereto and their
respective successors and permitted assigns.

      

      IN WITNESS WHEREOF, the
parties hereto have duly executed and delivered this Agreement as of the day and
year first above written.

      

      

      Dated:
May 22th
2009

      

      THE
COMPANY

      

      

      

      _____________________________________

      Karim
Menassa, Chairman, President, Director

      On Behalf
Of the Board

      

      

      THE
PURCHASER:

      

      

      

      

      _____________________________________

       

       

      - 8
-f8k050609ex10iv_mit.htm

    Exhibit
10.4

     

     

    NEITHER
THIS WARRANT NOR THE SHARES ISSUABLE UPON EXERCISE HEREOF HAVE BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY
OTHER APPLICABLE SECURITIES LAWS IN RELIANCE UPON AN EXEMPTION FROM THE
REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND SUCH OTHER SECURITIES
LAWS.  NEITHER THIS WARRANT NOR THE SHARES ISSUABLE UPON EXERCISE
HEREOF MAY BE SOLD, PLEDGED, TRASFERRED, ENCUMBERED OR OTHERWISE DISPOSED OF
EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT
OR IN A TRANSACTION THAT IS EXEMPT FROM REGISTRATION UNDER THE PROVISIONS OF THE
SECURITIES ACT.

    

    

    

    SERIES
“H” STOCK PURCHASE WARRANT

    

    To
Purchase

    

                      
    Shares of Common Stock

    of

    Medical
International Technology, Inc.

    

    

    THIS
CERTIFIES that, for value received,                       
, (the
“Holder”) is entitled, upon the terms and subject to the conditions hereinafter
set forth, at any time prior to the close of business on APRIL
15th , 2010, (the
“Termination Date”), but not thereafter, to subscribe for and purchase from
Medical International Technology, Inc.
(the “Company”), a corporation organized under the laws of the State of
Colorado, up to                  
      (         
)
shares (the “Warrant Shares”), of the common stock, $0.0001 par value, of the
Company (the “Common Stock”).  The purchase price of one share of
Common Stock (the “Exercise Price”) under this Series “H”
Stock Purchase Warrant (the “Warrant”) shall be $0.50.  The
Exercise Price and the number of shares for which the Warrant is exercisable
shall be subject to adjustment as provided herein.  Capitalized terms
used and not otherwise defined herein shall have the meanings set forth for such
terms in the Subscription Agreement dated as of October 27, 2005 (the
“Subscription Agreement”), between the Company and the Holder.  In the
event of any conflict between the terms of this Warrant and the Subscription
Agreement, the Subscription Agreement shall control.

    

    1. Title to
Warrant.  Prior to and subject to compliance with applicable
laws, this Warrant and all rights hereunder are transferable, in whole or in
part, at the office or agency of the Company by the Holder hereof in person or
by duly authorized attorney, upon surrender of this Warrant together with the
Assignment Form annexed hereto properly endorsed.

    

    2. Authorization of
Shares.  The Company covenants that all shares of Common Stock
that may be issued upon the exercise of rights represented by this Warrant will,
upon exercise of the rights represented by this Warrant, be duly authorized,
validly issued, fully-paid and nonassessable and free from all taxes, liens and
charges in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).

    

    

    
      
        
        

      

      
        Page 1 of
10

        
          

        

      

      
        
        

      

    

    

    

    
      	
              3.  

            	
              Exercise of
      Warrant.

            

    

    

    Except as
provided in Section 3(b) of Section 4 herein, exercise of the purchase rights
represented by this Warrant may be made at any time or times on or before the
close of business on the Termination Date by the surrender of this Warrant and
the Notice of Exercise form annexed hereto duly executed, at the office of the
Company (or such other office or agency of the Company as it may designate by
notice in writing to the registered Holder hereof at the address of such Holder
appearing on the books of the Company), and upon payment of the Exercise Price
of the Warrant Shares thereby purchased by wire transfer or cashier’s
check.  The Holder of this Warrant shall be entitled to receive a
certificate for the number of shares of the Common Stock so purchased.
Certificates for shares purchased hereunder shall be delivered to the Holder
hereof within seven (7) Trading Days after the date on which this Warrant shall
have been exercised as aforesaid.  This Warrant shall be deemed to
have been exercised and such certificate or certificates shall be deemed to have
been issued, and Holder or any other person so designated to be named therein
shall be deemed to have become a holder of record of such shares for all
purposes, as of the date the Warrant has been exercised by payment to the
Company of the Exercise Price and all taxes required to be paid by Holder, if
any, pursuant to Section 5 prior to the issuance of such shares, have been
paid.  If this Warrant shall have been exercised in part, the Company
shall, at the time of delivery of the certificate or certificates representing
Warrant Shares, deliver to Holder a new Warrant evidencing the rights of Holder
to purchase the unpurchased shares of Common Stock called for by this Warrant;
which new Warrant shall in all other respect be identical with this
Warrant.

    

    4. No Fractional Shares or
Scrip.  No fractional shares or scrip representing fractional
shares shall be issued upon the exercise of the Warrant.  As to any
fraction of a share that Holder would otherwise be entitled to purchase upon
such exercise, the Company shall pay a cash adjustment in respect of such
fraction of the Exercise Price based upon the Market Value on the date of
exercise.

    

    5. Charges, Taxes and
Expenses.  Issuance of certificates for shares of Common Stock
upon the exercise of this Warrant shall be made without charge to the Holder
hereof for any issue or transfer tax or other incidental expense in respect of
the issuance of such certificate, all of which taxes and expenses shall be paid
by the Company, and such certificates shall be issued in the name of the Holder
of this Warrant or in such name or names as may be directed by the Holder of
this Warrant; provided, however, that in the event certificates for shares of
Common Stock are to be issued in a name other than the name of the Holder of
this Warrant, this Warrant when surrendered for exercise shall be accompanied by
the Assignment Form attached hereto duly executed by the Holder hereof; and the
Company may require, as a condition thereto, the payment of a sum sufficient to
reimburse it for any transfer tax incidental thereto.

    

    6.Closing of
books.  The Company will not close its shareholder books or
records in any manner that prevents the timely exercise of this
Warrant.

    

    7. Transfer, Division and
Combination.  Subject to compliance with any applicable
securities laws, transfer of this Warrant and all rights hereunder, in whole or
in part, shall be registered on the books of the Company to be maintained for
such purpose, upon surrender of this Warrant at the principal office of the
Company, together with a written assignment of this Warrant substantially in the
form attached hereto duly executed by Holder or its agent or attorney, and
payment of funds sufficient to pay any transfer taxes payable upon the making of
such transfer.  Upon such surrender and, if required, such payment,
the Company shall execute and deliver a new Warrant or Warrants in the name of
the assignee or assignees and in the denomination or denominations specified in
such instrument of assignment, and shall issue to the assignor a new Warrant
evidencing the portion of this Warrant not so assigned, and this Warrant shall
promptly be cancelled. “H” Warrant, if properly
assigned, may be exercised by a new Holder for the purchase of shares of Common
Stock without having a new Warrant issued.

    

    
      
        
        

      

      
        Page 2 of
10

        
          

        

      

      
        
        

      

       

    

    (a)This
Warrant may be divided or combined with other Warrants upon presentation hereof
at the aforesaid office of the Company, together with a written notice
specifying the names and denominations in which new Warrants are to be issued,
signed by Holder or its agent or attorney.  Subject to compliance with
Section 7(a), as to any transfer that may be involved in such division or
combination, the Company shall execute and deliver a new Warrant or Warrants in
exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice.

    

    (i)The
Company shall prepare, issue and deliver at its own expense (other than transfer
taxes) the new Warrant or Warrants under this Section 7.

    

    (ii)The
Company agrees to maintain, at its aforesaid office, books for the registration
and the registration of transfer of the Warrants.

    

    8.No Rights as Shareholders
until Exercise.  This Warrant does not entitle the Holder
hereof to any voting rights or other rights as a shareholder of the Company
prior to its exercise.  Upon the surrender of this Warrant and the
payment of the aggregate Exercise Price, the Warrant Shares so purchased shall
be and be deemed to be issued to such Holder as the record owner of such shares
as of the close of business on the later of the date of such surrender or
payment.

    

    9.Loss, Theft, Destruction or
Mutilation of Warrant.  The Company covenants that upon receipt
by the Company of evidence reasonably satisfactory to it of the loss, theft,
destruction or mutilation of this Warrant certificate or any stock certificate
relating to the Warrant Shares, and in case of loss, theft or destruction, of
indemnity or security reasonably satisfactory to it (which shall not include the
posting of any bond), and upon surrender and cancellation of such Warrant or
stock certificate, if mutilated, the Company will make and deliver a new Warrant
or stock certificate of like tenor and dated as of such cancellation, in lieu of
such Warrant or stock certificate.

    

    10. Saturdays, Sundays,
Holidays, etc.  If the last or appointed day for the taking of
any action or the expiration of any right required or granted herein shall be a
Saturday, Sunday or a legal holiday, then such action may be taken or such right
may be exercised on the next succeeding day not a Saturday, Sunday or legal
holiday.

    

    11. Adjustments of Exercise
Price and Number of Warrant Shares.

    

    (a) Stock Splits,
etc.  The number and kind of securities purchasable upon the
exercise of this Warrant and the Exercise Price shall be subject to adjustment
from time to time upon the happening of any of the following.  In case
the Company shall (i) pay a dividend in shares of Common Stock or make a
distribution in shares of Common Stock to holders of its outstanding Common
Stock, (ii) subdivide its outstanding shares of Common Stock into a greater
number of shares of Common Stock, (iii) combine its outstanding shares of Common
Stock into a smaller number of shares of Common Stock or (iv) issue any shares
of its capital stock in a reclassification of the Common Stock, then the number
of Warrant Shares purchasable upon exercise of this Warrant immediately prior
thereto shall be adjusted so that the Holder of this Warrant shall be entitled
to receive the kind and number of Warrant Shares or other securities of the
Company which he would have owned or have been entitled to receive had such
Warrant been exercised in advance thereof.  Upon each such adjustment
of the kind and number of Warrant Shares or other securities of the Company
which are purchasable hereunder, the Holder of this Warrant shall thereafter be
entitled to purchase the number of Warrant Shares or other securities resulting
from such adjustment at an Exercise Price per Warrant Share or other security
obtained by multiplying the Exercise Price in effect immediately prior to such
adjustment by the number of Warrant Shares purchasable pursuant hereto
immediately prior to such adjustment and dividing by the number of Warrant
Shares or other securities of the Company resulting from such
adjustment.  An adjustment made pursuant to this paragraph shall
become effective immediately after the effective date of such event retroactive
to the record date, if any, for such event.

    

    
      
        
        

      

      
        Page 3 of
10

        
          

        

      

      
        
        

      

       

    

    (b) Reorganization,
Reclassification, Merger, Consolidation or Disposition of
Assets.  In case the Company shall reorganize its capital,
reclassify its capital stock, consolidate or merge with or into another
corporation (where the Company is not the surviving corporation or where there
is a change in or distribution with respect to the Common Stock of the Company),
or sell, transfer or otherwise dispose of all or substantially all is property,
assets or business to another corporation and, pursuant to the terms of such
reorganization, reclassification, merger, consolidation or disposition of
assets, shares of common stock or the successor or acquiring corporation, or any
cash, shares of stock or other securities or property of any nature whatsoever
(including warrants or other subscription or purchase rights) in addition to or
in lieu of common stock of the successor or acquiring corporation (“Other
Property”), are to be received by or distributed to the holders of Common Stock
of the Company, then Holder shall have the right thereafter to receive, upon
exercise of this Warrant, the number of shares of common stock of the successor
or acquiring corporation or of the Company, if it is the surviving corporation,
and Other Property receivable upon or as a result of such reorganization,
reclassification, merger, consolidation or disposition of assets by a holder of
the number of shares of Common Stock for which this Warrant is exercisable
immediately prior to such event.  In case of any such reorganization,
reclassification, merger, consolidation or disposition of assets, the successor
or acquiring corporation (if other than the Company) shall expressly assume the
due and punctual observance and performance of each and every covenant and
condition of this Warrant to be performed and observed by the Company and all
the obligations and liabilities hereunder, subject to such modifications as may
be deemed appropriate (as determined in good faith by resolution of the Board of
Directors of the Company) in order to provide for adjustments of shares of
Common Stock for which this Warrant is exercisable which shall be as nearly
equivalent as practicable to the adjustments provided for in this Section
11.  For purposes of this Section 11, “common stock of the successor
or acquiring corporation” shall include stock of such corporation of any class
which is not preferred as to dividends or assets over any other class of stock
of such corporation and which is not subject to redemption and shall also
include any evidences of indebtedness, shares of stock or other securities which
are convertible into or exchangeable for any such stock, either immediately or
upon the arrival of a specified date or the happening of a specified event and
any warrants or other rights to subscribe for or purchase any such
stock.  The foregoing provisions of this Section 11 shall similarly
apply to successive reorganizations, reclassifications, mergers, consolidations
or dispositions of assets.

    

    12.Voluntary Adjustment by the
Company.  The Company may at any time during the term of this
Warrant, reduce the then current Exercise Price to any amount and for any period
of time deemed appropriate by the Board of Directors of the
Company.

    

    
      
        
        

      

      
        Page 4 of
10

        
          

        

      

      
        
        

      

    

     

          
13.Notice of
Adjustment.  Whenever the number of Warrant Shares or number or
kind of securities or other property purchasable upon the exercise of this
Warrant or the Exercise Price is adjusted, as herein provided, the Company shall
promptly mail by registered or certified mail, return receipt requested, to the
Holder of this Warrant notice of such adjustment or adjustments setting forth
the number of Warrant Shares (and other securities or property) purchasable upon
the exercise of this Warrant and the Exercise Price of such Warrant Shares (and
other securities or property) after such adjustment, setting forth a brief
statement of the facts requiring such adjustment and setting forth the
computation by which such adjustment was made.  Such notice, in the
absence of manifest error, shall be conclusive evidence of the correctness of
such adjustment.

    

    
      	
              14.  

            	
              Notice of Corporate
      Action.  If any
time:

            

    

    

    (a) the
Company shall take a record of the holders of its Common Stock for the purpose
of entitling them to receive a dividend or  other distribution, or any
right to subscribe for or purchase any evidences of its indebtedness, any shares
of stock of any class of any other securities or property, or to receive any
other right, or

    

    (b)there
shall be any capital reorganization of the Company, any reclassification or
recapitalization of the capital stock of the Company or any consolidation or
merger of the Company with, or any sale, transfer or other disposition of all or
substantially all the property, assets or business of the Company to, another
corporation or,

    

    (c)there
shall be a voluntary or involuntary dissolution, liquidation or winding up of
the Company; then, in any one or more of such cases, the Company shall give to
Holder (i) at least 30 days’ prior written notice of the date on which a record
date shall be selected for such dividend, distribution or right or for
determining rights to vote in respect of any such reorganization,
reclassification, merger, consolidation, sale, transfer, disposition,
liquidation or winding up, and (ii) in the case of any such reorganization,
reclassification, merger, consolidation, sale, transfer, disposition,
dissolution, liquidation or winding up, at least 30 days’ prior written notice
of the date when the same shall take place.  Such notice in accordance
with the foregoing clause also shall specify (i) the date on which any such
record is to be taken for the purpose of such dividend, distribution or right,
the date on which the holders of Common Stock shall be entitled to any such
dividend, distribution or right, and the amount and character thereof, and (ii)
the date on which any such reorganization, reclassification, merger,
consolidation, sale, transfer, disposition, dissolution, liquidation or winding
up is to take place and the time, if any such time is to be fixed, as of which
the holders of Common Stock shall be entitled to exchange their shares of Common
Stock for securities or other property deliverable upon such disposition,
dissolution, liquidation or winding up.  Each such written notice
shall be sufficiently given if the addressed to Holder at the last address of
Holder appearing on the books of the Company and delivered in accordance with
Section 16(d).

    

    
      	
              15.  

            	
              Authorized
      Shares.

            

    

    

    (a)Then
Company covenants that during the period the Warrant is outstanding, it will
reserve from its authorized and unissued Common Stock a sufficient number of
shares to provide for the issuance of the Warrant Shares upon the exercise of
any purchase rights under this Warrant.  The Company further covenants
that its issuance of this Warrant shall constitute full authority to its
officers who are charged with the duty of executing stock certificates to
execute and issue the necessary certificates for the Warrant Shares upon the
exercise of the purchase rights under this Warrant.  The Company will
take all such reasonable action as may be necessary to assure that such Warrant
Shares may be issued as provided herein without violation of any applicable law
or regulation, or of any requirements of the Principal Market upon which the
Common Stock may be listed.

    

    
      
        
        

      

      
        Page 5 of
10

        
          

        

      

      
        
        

      

    

     

    (b) The
Company shall not by any action, including, without limitation, amending its
certificate of incorporation or through any reorganization, transfer of assets,
consolidation, merger, dissolution, issue or sale of securities or any other
voluntary action, avoid or seek to avoid the observance or performance of any of
the terms of this Warrant, but will at all times in good faith assist in the
carrying out of all such terms and in the taking of all such actions as may be
necessary or appropriate to protect the rights of Holder against
impairment.  Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any shares of Common Stock
receivable upon the exercise of this Warrant above the amount payable therefore
upon such exercise immediately prior to such increase in par value, (ii) take
all such action as may be necessary or appropriate in order that the Company may
validly and legally issue fully paid and nonassessable shares of Common Stock
upon the exercise of this Warrant, and (iii) use its best efforts to obtain all
such authorizations, exemptions or consents from any public regulatory body
having jurisdiction thereof as may be necessary to enable the Company to perform
its obligations under this Warrant.

    

    (c)Upon
request of Holder, the Company will at any time during the period this Warrant
is outstanding acknowledge in writing, in form reasonably satisfactory to
Holder, the continuing validity of this Warrant and the obligations of the
Company hereunder.

    

    (d)Before
taking any action pursuant to Section 11 or 12 that would cause an adjustment
reducing the current Exercise Price below the then par value, if any, of the
shares of Common Stock issuable upon exercise of the Warrants, the Company shall
take any corporate action that may be necessary in order that the Company may
validly and legally issue fully-paid and nonassessable shares of the Common
Stock at such adjusted Exercise Price.

    

    (e) Before
taking any action that would result in an adjustment in the Exercise Price, the
Company shall obtain all such authorizations or exemptions thereof, or consents
thereto, as may be necessary from any public regulatory body or bodies having
jurisdiction thereof.

    

    
      	
              16.  

            	
              Miscellaneous.

            

    

    

    (a)Jurisdiction.  This
Warrant shall be binding upon any successors or assigns of the
Company.  This Warrant shall constitute a contract under the laws of
Colorado without regard to its conflict of law principles or rules, and be
subject to arbitration pursuant to the terms set forth in the Securities
Purchase Agreement.

    

    (b)Restrictions.  The
Holder hereof acknowledges that the Warrant Shares acquired upon the exercise of
this Warrant, if not registered, will have all required resale restrictions
imposed by the state and federal securities laws.

    

    (c)Nonwaiver and
Expenses.  No course of dealing in any delay or failure to
exercise any right hereunder on the part of Holder shall operate as a waiver of
such right or otherwise prejudice Holder’s rights, powers or remedies;
notwithstanding which all rights hereunder terminate on the Termination
Date.  If the Company fails to comply with any provision of this
Warrant, the Company shall pay to Holder such amounts as shall be sufficient to
cover any costs and expenses including, but not limited to, reasonable
attorneys’ fees, including those of appellate proceedings, incurred by Holder in
collecting any amounts due pursuant hereto or in otherwise enforcing any of its
rights, powers or remedies hereunder.

    

    
      
        
        

      

      
        Page 6 of
10

        
          

        

      

      
        
        

      

    

     

    (d)Notices.  Any
notice, request or other document required or permitted to be given or delivered
to the Holder hereof by the Company shall be delivered in accordance with the
notice of provisions of the Securities Purchase Agreement.

    

    (e)Limitation of
Liability.  No provision hereof, in the absence of affirmative
action by Holder to purchase shares of Common Stock, and no enumeration herein
of the rights or privileges of Holder hereof, shall give rise to any liability
of Holder for the purchase price of any Common Stock or as a stockholder of the
Company, whether such liability is asserted by the Company or by creditors of
the Company.

    

    (f)Remedies.  Holder,
in addition to being entitled to exercise all rights granted by law, including
recovery of damages, will be entitled to specific performance of its rights
under this Warrant.  The Company agrees that monetary damages would
not be adequate compensation for any loss incurred by reason of a breach by it
of the provisions of this Warrant and hereby agrees to waive the defense in any
action for specific performance that a remedy at law would be
adequate.

    

    (g)Successors and
Assigns.  Subject to applicable securities laws, this Warrant
and the rights and obligations evidenced hereby shall inure to the benefit of
and be binding upon the successors of the Company and the successors and
permitted assigns of Holder.  The provisions of this Warrant are
intended to be for the benefit of all Holders from time to time of this Warrant
and shall be enforceable by any such Holder or holder of Warrant
Shares.

    

    (h)Indemnification.  The
Company agrees to indemnify and hold harmless Holder from and against any
liabilities, obligations, losses, damages, penalties, actions, judgments, suits,
claims, costs, attorneys’ fees, expenses and disbursements of any kind that may
be imposed upon, incurred by or asserted against Holder in any manner relating
to or arising out of any failure by the Company to perform or observe in any
material respect any of its covenants, agreements, undertakings or obligations
set forth in this Warrant; provided, however, that the Company will not be
liable hereunder to the extent that any liabilities, obligations, losses,
damages, penalties, actions, judgments, suits, claims, costs, attorneys’ fees,
expenses or disbursements are found in a final non-appealable judgment by a
court to have resulted from Holder’s negligence, bad faith or willful misconduct
in its capacity as a stockholder or warrant holder of the Company.

    

    (i)Amendment.     This
Warrant may be modified or amended or the provisions hereof waived with the
written consent of the Company and the Holder.

    

    (j)Severability.     Wherever
possible, each provision of this Warrant shall be interpreted in such manner as
to be effective and valid under applicable law, but if any provision of this
Warrant shall be prohibited by or invalid under applicable law, such provision
shall be infective to the extent of such prohibition or invalidity, without
invalidating the remainder of such provisions or the remaining provisions of
this Warrant.

    

    (k)Headings.     The
headings used in this Warrant are for the convenience of reference only and
shall not, for any purpose, be deemed a part of this Warrant.

     

    
      
        
        

      

      
        Page 7 of
10

        
          

        

      

      
        
        

      

    

    

     

     

     

    IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its
officer thereunto duly authorized.

    

    Dated:
April 15th 2009

    

    MEDICAL INTERNATIONAL
TECHNOLOGY, INC.

    

    

    

      
        

      

    

    Karim
Menassa

    Chairman,
President, Director

    

     

     

    
 

    
      
        
        

      

      
        Page 8 of
10

        
          

        

      

      
        
        

      

       

    

    NOTICE
OF EXERCISE

    

    

    To:
MEDICAL INTERNATIONAL TECHNOLOGY, INC.

    

    

    

    1.The undersigned hereby
elects to purchase            
       (               
)  shares
of common stock, $0.50
per share (the “Common Stock”), of Medical International Technology, Inc.,
pursuant to the terms of the attached Warrant, and he tenders herewith payment
of the exercise price in full, together with all applicable transfer taxes, if
any.

    

    2. Please issue a certificate or
certificates representing said shares of Common Stock in the name of the
undersigned or in such other name as is specified below:

    

    
      
        
(Name)

    

    

            

     

    
      
        

      

    

    (Address)

     

     

     

    
      
        

      

    

    (Address)

    

    

    

    Dated:    __________________________________

                                
  Signature                              

    

    

    
      
        
        

      

      
        Page 9 of
10

        
          

        

      

      
        
        

      

    

    

    

    

    
      ASSIGNMENT
FORM

      

      (To
assign the foregoing Warrant, execute

      this form
and supply required information.

      Do no use
this form to exercise the Warrant.)

    

    
      

      FOR VALUE RECEIVED,the
foregoing Warrant and all rights evidenced thereby are hereby assigned
to:

      

                                                                                                                                                                                                                                                
              
, whose address is

      

                                                                                                                                                                                                                                                                                     
          .

    

          

     

    Dated:
____________, ________

    

     Holder’s
Signature:                                                            
         

     

     Holder’s
Address:                    
                                                

     

                                                                                                

    

                  

    Signature
Guaranteed:

    

                                                                                                                                                                                                                                                                                                 

    

    NOTE:  This
signature to this Assignment Form must correspond with the name as it appears on
the face of the Warrant, without alternation or enlargement or any change
whatsoever, and must be guaranteed by a bank or trust
company.  Officers of corporations and those acting in a fiduciary or
other representative capacity should file proper evidence of authority to assign
the foregoing Warrant.

    

     

     

    Page 9 of 10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00163-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00163-of-00352.parquet"}]]